Tal Zvi Zaks, Chief Medical Officer at Moderna, Inc. (MRNA), sold 5,000 shares at $162.47 ($824K) on 2021-02-22, disclosed to the SEC on 2021-02-24.
Open-market sale of $824k MRNA by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $159.32 | 263 | $42K | 5.1% |
| 2 | $160.38 | 100 | $16K | 1.9% |
| 3 | $162.47 | 800 | $130K | 15.8% |
| 4 | $163.57 | 1,100 | $180K | 21.8% |
| 5 | $164.60 | 300 | $49K | 6.0% |
| 6 | $165.95 | 1,000 |
| $166K |
| 20.1% |
| 7 | $166.82 | 700 | $117K | 14.2% |
| 8 | $168.00 | 356 | $60K | 7.3% |
| 9 | $168.90 | 281 | $47K | 5.8% |
| 10 | $169.81 | 100 | $17K | 2.1% |
| Total | $164.84 avg | 5,000 | $824K | 100% |
| Filing → |
| MRNA | SELL | 2021-06-25 | $1.1M | — | Filing → |
| MRNA | SELL | 2021-06-21 | $1.0M | — | Filing → |
| MRNA | SELL | 2021-06-11 | $1.1M | — | Filing → |